I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
COVID-19 vaccine-induced antibody and T cell responses in i..:
Alexander, J
;
Liu, Z
;
Munoz Sandoval, D
...
The Lancet Gastroenterology & Hepatology. , 2022
Link:
http://hdl.handle.net/10044/1/99045
RT Journal T1
COVID-19 vaccine-induced antibody and T cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose: a multicentre, prospective, case-control study
UL https://suche.suub.uni-bremen.de/peid=base-ftimperialcol:oai:spiral.imperial.ac.uk:10044_1_99045&Exemplar=1&LAN=DE A1 Alexander, J A1 Liu, Z A1 Munoz Sandoval, D A1 Reynolds, C A1 Ibraheim, H A1 Saifuddin, M A1 Constable, L A1 Altmann, D A1 Balarajah, S A1 Hicks, L A1 Williams, H A1 Teare, J A1 Hart, A A1 Boyton, R A1 Powell, N PB Elsevier YR 2022 K1 Antibodies K1 Viral K1 COVID-19 K1 COVID-19 Vaccines K1 Case-Control Studies K1 Humans K1 Immunosuppressive Agents K1 Inflammatory Bowel Diseases K1 Infliximab K1 Janus Kinase Inhibitors K1 Prospective Studies K1 SARS-CoV-2 K1 T-Lymphocytes K1 Tumor Necrosis Factor Inhibitors K1 Ustekinumab K1 VIP study investigators JF The Lancet Gastroenterology & Hepatology LK http://hdl.handle.net/10044/1/99045 DO http://hdl.handle.net/10044/1/99045 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)